FOCL

Peers: PROF PRCT BSX SNWV URGN TFX ARAY ICCM HSIC ISRG

Index	-
Market Cap	158.92M
Enterprise Value	179.06M
Income	-38.89M
Sales	69.14M
Book/sh	-0.09
Cash/sh	0.57
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	289
IPO	Aug 01, 1997

P/E	-
Forward P/E	-
PEG	-
P/S	2.30
P/B	-
P/C	7.38
P/FCF	-
EV/EBITDA	-
EV/Sales	2.59
Quick Ratio	1.38
Current Ratio	1.60
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-1.04
EPS next Y	-0.81
EPS next Q	-0.24
EPS this Y	-33.08%
EPS next Y	24.06%
EPS next 5Y	7.02%
EPS past 3/5Y	-106.02% -63.72%
Sales past 3/5Y	6.90% 8.30%
EPS Y/Y TTM	-81.03%
Sales Y/Y TTM	-
EPS Q/Q	-127.30%
Sales Q/Q	-27.49%
Earnings	Nov 05 AMC
EPS/Sales Surpr.	-81.23% -12.49%

Insider Own	0.53%
Insider Trans	173.45%
Inst Own	49.74%
Inst Trans	1.01%
ROA	-50.16%
ROE	-263.75%
ROIC	-111.73%
Gross Margin	48.73%
Oper. Margin	-39.32%
Profit Margin	-56.25%
SMA20	1.38%
SMA50	-0.28%
SMA200	-3.83%
Trades

Shs Outstand	37.48M
Shs Float	37.28M
Short Float	0.90%
Short Ratio	3.07
Short Interest	0.33M
52W High	6.40 -33.75%
52W Low	1.82 132.97%
Volatility	6.36% 6.16%
ATR (14)	0.25
RSI (14)	49.96
Beta	-0.01
Rel Volume	0.22
Avg Volume	108.89K
Volume	9,065

Perf Week	0.24%
Perf Month	0.95%
Perf Quarter	-33.12%
Perf Half Y	26.95%
Perf YTD	28.88%
Perf Year	98.13%
Perf 3Y	-39.34%
Perf 5Y	-29.80%
Perf 10Y	56.80%
Recom	2.00
Target Price	8.50
Prev Close	4.18
Price	4.24
Change %	1.44%

Consensus

Buy

Avg. Price Target

$8.50

Implied Upside

+100.5%

Analysts8incl. previous ratings

Rating Distribution4 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 17, 2026	Initiated	MMizuho	Outperform	$15	+253.8%
May 15, 2025	Downgrade	PPiper Sandler	Overweight → Neutral
Apr 04, 2025	Downgrade	JJefferies	Buy → Hold	$2	-52.8%
Nov 01, 2022	Initiated	JJefferies	Buy	$11	+159.4%
Apr 28, 2021	Initiated	PPiper Sandler	Overweight	$13	+206.6%
Apr 15, 2020	Initiated	BB. Riley FBR	Buy	$5.50	+29.7%
Jul 28, 2014	Downgrade	NNorthland Capital	Outperform → Market Perform	$6 → $3.50	-17.5%
Jun 16, 2014	Initiated	HH.C. Wainwright	Buy	$6	+41.5%
Mar 05, 2013	Initiated	NNorthland Capital	Outperform	$6	+41.5%
Nov 18, 2010	Reiterated	MMorgan Joseph	Buy	$3 → $5.25	+23.8%
Aug 20, 2009	Reiterated	RRoth Capital	Hold	$2.50 → $5	+17.9%
Nov 24, 2008	Reiterated	RRoth Capital	Hold	$2.50	-41.0%
Mar 26, 2008	Reiterated	RRoth Capital	Hold	$6 → $4.50	+6.1%
Nov 09, 2007	Reiterated	RRoth Capital	Hold	$7 → $6	+41.5%
Mar 16, 2007	Reiterated	RRoth Capital	Hold	$8.50 → $7	+65.1%
Jan 24, 2007	Reiterated	RRoth Capital	Hold	$6.50 → $8.50	+100.5%

Oct-28-26 07:50PM	FocalTherics Must Square A Sequential Revenue Dip With A Reaffirmed $50 Million Floor (Earnings Whispers)
Oct-22-26 04:30PM	FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire) -5.03%
Sep-01-26 07:30AM	FocalTherics to Present at the H.C. Wainwright 28th Annual Global Investment Conference (GlobeNewswire)
Aug-14-26 01:04AM	Edap TMS SA (FOCL) (Q2 2026) Earnings Call Highlights: HIFU Revenue Surges 39% as Company ... (GuruFocus.com)
Aug-13-26 04:02PM	FocalTherics Reports Second Quarter 2026 Financial Results (GlobeNewswire)
09:10PM	Loading…
Aug-11-26 09:10PM	FocalTherics Announces Pricing of Public Offering of American Depositary Shares (GlobeNewswire) -20.97%
04:28PM	FocalTherics Reports Preliminary Financial Results for Second Quarter of 2026 (GlobeNewswire)
04:22PM	FocalTherics Announces Proposed Public Offering of American Depositary Shares (GlobeNewswire)
Jul-30-26 05:00PM	FocalTherics to Announce Second Quarter 2026 Financial Results on August 13, 2026 (GlobeNewswire)
Jun-30-26 07:30AM	FocalTherics Announces Successful Launch of First Commercial Endometriosis Focal One Program in Europe with Treatment of Initial Patients (GlobeNewswire)
Jun-16-26 07:30AM	FocalTherics Expands Access to Focal One Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical (GlobeNewswire)
May-29-26 07:30AM	EDAP Announces Corporate Name Change to FocalTherics to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy (GlobeNewswire)
May-21-26 07:30AM	EDAP Focal One to Present at Jefferies 2026 Global Healthcare Conference (GlobeNewswire)
May-14-26 07:30AM	EDAP Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer (GlobeNewswire)
May-13-26 04:30PM	EDAP Focal One to Host Investor Day on June 1, 2026 (GlobeNewswire)
07:30AM	Loading…
May-07-26 07:30AM	EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue (GlobeNewswire) +15.72%
Apr-30-26 08:30AM	EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One Robotic HIFU in Radiorecurrent Prostate Cancer (GlobeNewswire)
Apr-16-26 07:30AM	EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Mar-25-26 03:01PM	Edap TMS SA (EDAP) Q4 2025 Earnings Call Highlights: Robust HIFU Growth Amid Revenue Challenges (GuruFocus.com) -5.12%
07:30AM	EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue (GlobeNewswire)
Mar-10-26 07:30AM	EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Mar-09-26 08:17AM	ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last? (Zacks)
Mar-04-26 07:30AM	EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 (GlobeNewswire) +6.52%
Feb-12-26 07:30AM	EDAP Announces Appointment of David Horn to Board of Directors (GlobeNewswire)
Jan-12-26 07:30AM	EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance (GlobeNewswire) +11.41%
Dec-30-25 10:42AM	RBOT Enters Strategic Software Partnership to Streamline Development (Zacks)
Dec-26-25 12:20PM	EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy (Zacks) +14.47%
Dec-11-25 10:06AM	ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries (Zacks)
Nov-20-25 07:30AM	EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU (GlobeNewswire) +5.83%
Nov-18-25 07:00AM	EDAP to Present at Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
04:00PM	Loading…
Nov-06-25 04:00PM	Edap TMS SA (EDAP) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth in HIFU (GuruFocus.com)
07:30AM	EDAP Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:00AM	EDAP to Present at Jefferies Global Healthcare Conference in London (GlobeNewswire)
Oct-27-25 07:00AM	EDAP to Participate in the UBS Global Healthcare Conference (GlobeNewswire)
Oct-23-25 07:00AM	EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-20-25 08:30AM	EDAP Secures 36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One Robotic HIFU (GlobeNewswire) +5.80%
Oct-17-25 09:50AM	Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation (PR Newswire) -7.44%
Sep-30-25 07:00AM	Focal One Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option (GlobeNewswire)
Sep-16-25 07:00AM	Focal One HIFU Receives Prestigious Innovation Award (GlobeNewswire)
Sep-08-25 07:00AM	EDAP Receives HIFU Reimbursement for Prostate Cancer in France (GlobeNewswire) +8.73%
Aug-28-25 07:00AM	EDAP Reports Strong Second Quarter 2025 HIFU Results (GlobeNewswire) +15.19%
Aug-27-25 09:29AM	Edap TMS SA (EDAP) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-26-25 07:00AM	EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion (GlobeNewswire) +10.95%
Aug-25-25 07:00AM	EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-07-25 07:00AM	EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025 (GlobeNewswire)
Jul-04-25 04:19AM	North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE (GlobeNewswire)
Jul-01-25 07:00AM	EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status (GlobeNewswire)
May-27-25 07:00AM	EDAP to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-16-25 03:09AM	Edap TMS SA (EDAP) Q1 2025 Earnings Call Highlights: Record Focal One Placements Amid Revenue ... (GuruFocus.com)
May-15-25 07:00AM	EDAP Reports First Quarter 2025 Financial Results (GlobeNewswire) -18.52%
May-14-25 09:56AM	Edap TMS SA (EDAP) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-01-25 07:00AM	EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025 (GlobeNewswire)
Apr-30-25 09:01AM	Strong Segmental Performance to Drive Stryker's Q1 Earnings? (Zacks)
Apr-29-25 09:05AM	DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
07:00AM	EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting (GlobeNewswire)
Apr-28-25 01:19PM	Will BAX's Q1 Earnings Improve Following Transformation Completion? (Zacks)
Apr-24-25 07:00AM	EDAP To Launch New Focal One i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting (GlobeNewswire) +20.86%
Apr-22-25 07:00AM	EDAP Announces Significant Presence of Focal One at the Upcoming 120th American Urological Association (AUA) Annual Meeting (GlobeNewswire)
Mar-28-25 03:01AM	Edap TMS SA (EDAP) Q4 2024 Earnings Call Highlights: Strong HIFU Growth Amidst Strategic Shifts (GuruFocus.com)
Mar-27-25 11:56AM	EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript (SeekingAlpha) +8.29%
07:10AM	EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
Mar-06-25 07:00AM	EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 (GlobeNewswire)
Mar-03-25 07:00AM	EDAP Appoints Glen French to Board of Directors (GlobeNewswire)
Feb-06-25 08:00AM	Cortechs.ai and EDAP Announce World's First OnQ Prostate-Assisted Focal One Robotic HIFU Procedure at UCSF Prostate Cancer Center (GlobeNewswire)
Jan-13-25 07:00AM	EDAP Announces Preliminary Record Fourth Quarter Focal One System Sales and Record U.S. Procedures (GlobeNewswire)
Jan-10-25 07:00AM	EDAP Appoints Joshua H. Levine to Board of Directors (GlobeNewswire)
Jan-08-25 07:00AM	EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology (GlobeNewswire) -13.73%
Dec-04-24 09:10AM	Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One Robotic HIFU Versus Surgery in the Management of Prostate Cancer (GlobeNewswire) -5.88%
Dec-02-24 07:00AM	Senti Bio Appoints Fran Schulz to Board of Directors (GlobeNewswire)
Nov-27-24 07:00AM	EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-22-24 08:00AM	EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting (GlobeNewswire)
Nov-19-24 08:00AM	EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis (GlobeNewswire)
Nov-08-24 06:02AM	Edap TMS SA (EDAP) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amidst Rising Expenses (GuruFocus.com) -6.04%
Nov-07-24 07:00AM	EDAP Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 08:00AM	EDAP to Participate in the 2024 Jefferies London Healthcare Conference (GlobeNewswire)
07:50AM	Edap TMS SA (EDAP) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Oct-30-24 01:01AM	Q3 2024 McDonald's Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-24-24 08:00AM	EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-01-24 07:00AM	EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH) (GlobeNewswire) +6.27%
Sep-19-24 08:00AM	EDAP and Avenda Health Launch World's First AI-Assisted Focal One Robotic HIFU Procedures (GlobeNewswire)
Aug-29-24 08:00AM	EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) +9.03%
Aug-28-24 07:00AM	EDAP Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-07-24 07:00AM	EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024 (GlobeNewswire)
Aug-06-24 07:00AM	EDAP's Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024) (GlobeNewswire)
Jul-22-24 06:33AM	EDAP high-intensity ultrasound therapy fails in Phase III interim data (Medical Device Network)
Jul-19-24 04:15PM	EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis (GlobeNewswire)
Jul-08-24 07:00AM	EDAP Appoints Fran Schulz to Board of Directors (GlobeNewswire)
Jun-03-24 08:00AM	EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations (GlobeNewswire) -9.41%
May-22-24 08:00AM	EDAP to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-17-24 08:10AM	EDAP TMS S.A. (NASDAQ:EDAP) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-16-24 12:52PM	EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00AM	EDAP Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 08:00AM	EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting (GlobeNewswire)
May-02-24 08:00AM	EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024 (GlobeNewswire)
Apr-23-24 08:00AM	EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting (GlobeNewswire)
Mar-29-24 09:44AM	EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 11:53AM	EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
07:00AM	EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Mar-13-24 07:00AM	EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024 (GlobeNewswire)
Mar-06-24 07:00AM	EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Horn David R.	Director	Aug 14 '26	Buy	4.75	10,000	47,500	10,000	Aug 17 06:06 AM
Schulz Fran	Director	Aug 14 '26	Buy	4.75	10,000	47,500	15,100	Aug 17 06:04 AM
LEVINE JOSHUA	Director	Aug 14 '26	Buy	4.75	10,000	47,500	45,000	Aug 17 06:04 AM
Mobeck Kenneth S.	Chief Financial Officer	Aug 14 '26	Buy	4.75	5,000	23,750	181,610	Aug 17 06:02 AM
WILLSEY LANCE	Director	Aug 14 '26	Buy	4.75	50,000	237,500	1,291,780	Aug 17 06:01 AM
Rhodes Ryan	Chief Executive Officer	Aug 14 '26	Buy	4.75	21,000	99,750	626,649	Aug 17 06:01 AM
Shah Sanket	General Counsel & Corp Sec	Aug 14 '26	Buy	4.75	5,000	23,750	72,500	Aug 17 06:01 AM
Annen Steven	SVP, Marketing & Product Mgmt.	Aug 14 '26	Buy	4.75	5,000	23,750	136,490	Aug 17 06:00 AM
LEVINE JOSHUA	Director	May 11 '26	Buy	4.22	10,000	42,200	35,000	May 13 06:03 AM

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

CEO & DirectorMr. Ryan Rhodes

Chief Financial OfficerMr. Kenneth Mobeck

Executive Vice President of Marketing & Product ManagementMr. Steven Annen

Chief Operating OfficerMr. Carre Emmanuel

Chief Accounting OfficerMr. Francois Dietsch

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EDAP TMS SA ADR

Upgrade your Finviz experience